Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRS Group Regulatory News (RS1)

Share Price Information for RS Group (RS1)

Share Price is delayed by 15 minutes
Get Live Data
618.00    -2.00 (-0.32%)
Bid:
617.50
Ask:
618.50
Spread: 1.00 (0.162%)
Market Cap: £2.86b
RS1 Live PriceLast checked at - London Stock Exchange

Intraday RS Group Share Chart

Director Declaration

8 Jan 2025 09:13

RNS Number : 5801S
RS Group PLC
08 January 2025
 

 

 

RS Group plc

 

Director Declaration

 

 

RS Group plc announces that Carole Cran, Non-Executive Director, has been appointed as CFO designate of Halma plc, a listed company on the London Stock Exchange, with immediate effect. From 1 April 2025, Carole will become CFO of Halma plc. Carole previously served as independent non-executive director of Halma plc from January 2016.

 

 

Clare Underwood

Company Secretary

8 January 2025

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNPKFBDCBKKBDK
Date   Source Headline
3rd Jul 20238:00 amRNSCompletion of Distrelec Acquisition
30th Jun 202312:09 pmRNSNotice of Trading Update
20th Jun 202312:00 pmRNSDirector/PDMR Shareholding
15th Jun 20232:00 pmRNSDirector/PDMR Shareholding
14th Jun 20239:00 amRNSHolding(s) in Company
7th Jun 202312:00 pmRNSAnnual Financial Report
1st Jun 20239:25 amRNSTotal Voting Rights
30th May 202312:00 pmRNSDirector/PDMR Shareholding
30th May 202312:00 pmRNSDirector/PDMR Shareholding
26th May 202310:00 amRNSDirector/PDMR Shareholding
24th May 20238:00 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSFinal Results
15th May 202310:00 amRNSBoard Committee Change
3rd May 20237:00 amRNSDirectorate Change
2nd May 202310:00 amRNSTotal Voting Rights
27th Apr 20237:00 amRNSAcquisition
13th Apr 20233:43 pmRNSHolding(s) in Company
5th Apr 20237:00 amRNSQ4 Trading Statement
3rd Apr 202310:00 amRNSTotal Voting Rights
30th Mar 20239:00 amRNSChange of Auditor
21st Mar 20239:00 amRNSBlock Listing Application
17th Mar 20234:08 pmRNSNotice of Trading Update: Change of Date
14th Mar 20231:42 pmRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSAppointment of Simon Pryce as CEO
9th Mar 20238:00 amRNSNotice of Trading Update
1st Mar 202312:19 pmRNSTotal Voting Rights
10th Feb 20234:20 pmRNSHolding(s) in Company
1st Feb 20238:51 amRNSBlock listing Interim Review
1st Feb 20238:45 amRNSTotal Voting Rights
26th Jan 20233:00 pmRNSAdditional Listing
13th Jan 20239:00 amRNS2022 AGM Vote Outcome Update Statement
10th Jan 20237:00 amRNSTrading Statement
9th Jan 20234:30 pmRNSDirector/PDMR Shareholding
4th Jan 20237:00 amRNSCompletion of Risoul Acquisition
3rd Jan 20237:00 amRNSTotal Voting Rights
28th Dec 20229:13 amRNSHolding(s) in Company
16th Dec 20227:00 amRNSHolding(s) in Company
16th Dec 20227:00 amRNSDirectorate Change
1st Dec 20224:54 pmRNSTotal Voting Rights
7th Nov 20227:13 amRNSDirector Declaration
3rd Nov 20227:01 amRNSHalf-year Report
3rd Nov 20227:00 amRNSCEO Leave of Absence
1st Nov 202210:54 amRNSTotal Voting Rights
6th Oct 20227:00 amRNSTrading Statement
3rd Oct 202211:00 amRNSTotal Voting Rights
28th Sep 20221:41 pmRNSNotice of Trading Update
21st Sep 202211:00 amRNSHolding(s) in Company
1st Sep 20224:02 pmRNSAppointment of Joint Corporate Broker
1st Sep 202212:05 pmRNSTotal Voting Rights
17th Aug 202211:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.